A letter from Metsera to the court indicates that Metsera estimates Novo Nordisk's latest offer to be between $69.82 and $70.18 per share. FXBus

Sydney：12/24 22:26:56

Tokyo：12/24 22:26:56

Hong Kong：12/24 22:26:56

Singapore：12/24 22:26:56

Dubai：12/24 22:26:56

London：12/24 22:26:56

New York：12/24 22:26:56

Live Updates > Live Update Details

2025-11-06 03:09:32

A letter from Metsera to the court indicates that Metsera estimates Novo Nordisk's latest offer to be between $69.82 and $70.18 per share.

11-06 07:33

11-06 01:48

11-06 01:33

11-06 01:15

Risk Disclosure: Trading stocks, currencies, commodities, futures, bonds, funds or cryptocurrencies involves significant risks. These risks include the loss of part or all of your investment capital, so trading is not suitable for all investors. Before making any financial decision, you should conduct your own due diligence, use your own judgment, and consult a qualified advisor. The content on this website is not specifically directed at you, nor have we considered your financial situation or needs. Information provided on this site may not be real-time or accurate. Prices shown on this website may be provided by market makers rather than exchanges. You are solely responsible for any trades or financial decisions made based on the information from this site, and you must not rely on such information. We make no guarantees regarding any information on the website and assume no responsibility for any trading losses caused by the use of this information. Use, storage, copying, display, modification, dissemination or distribution of the data contained on this site is prohibited without prior written permission. All intellectual property rights in the data provided on this site are reserved by the respective data providers and exchanges.

Download App